Zobrazeno 1 - 10
of 13
pro vyhledávání: '"M. V. Avksentyeva"'
Autor:
K. V. Gerasimova, D. V. Fedyaev, M. V. Sura, A. A. Tikhonova, V. V. Omelyanovskiy, M. V. Avksentyeva
Publikováno v:
Фармакоэкономика, Vol 9, Iss 1, Pp 69-78 (2016)
Objective. To examine approaches to organization and planning as well as expenditures of inpatient care in countries outside of Russia.Methods. A narrative review of published articles and legal documents was conducted. The review focused on health s
Externí odkaz:
https://doaj.org/article/4a37f1618252436ca38fdf898e802e1b
Publikováno v:
Фармакоэкономика, Vol 8, Iss 4, Pp 50-61 (2016)
Externí odkaz:
https://doaj.org/article/861fbaff8e4b4412a96011a2a9ac842c
Autor:
A. E. Platonov, N. A. Avksentyev, M. V. Avksentyeva, E. V. Derkach, O. V. Platonova, A. V. Titkov, N. M. Kolyasnikova
Publikováno v:
Фармакоэкономика, Vol 8, Iss 1, Pp 47-56 (2015)
Study objective: to perform assessment of the social and economic burden (analysis of the cost of disease) of five natural focal transmitted infectious diseases in theRussian Federationon the whole and in certain regions: ixodic tick-borne borreliosi
Externí odkaz:
https://doaj.org/article/01d76a96ce064926bd942c6a723d247c
Publikováno v:
Фармакоэкономика, Vol 7, Iss 3, Pp 36-43 (2015)
Externí odkaz:
https://doaj.org/article/16864b49a3a349e0a1a2de83a051067d
Publikováno v:
Терапевтический архив, Vol 88, Iss 1, Pp 75-81 (2016)
Aim. To analyze one-year typical management practice in outpatients with type 2 diabetes mellitus (T2DM) in cities, towns, and villages. Subjects and methods. 438 records of T2DM outpatients regularly visiting their physicians during 2009 were retros
Externí odkaz:
https://doaj.org/article/dcf928d1fed2462b925a53d7de9183dd
Autor:
E A Pyadushkina, K V Gerasimova, S V Goryainov, Vitaly Vladimirovich Omelyanovsky, M V Avksentyeva, I S Krysanov
Publikováno v:
Современная ревматология, Vol 6, Iss 4, Pp 89-96 (2012)
Objective: to make a pharmacoeconomic analysis of the use of oral (a 150-mg tablet once a month) and injectable (a solution for intravenous bolus injection of 3 mg in 3 ml once every 3 months) ibandronate in patients with postmenopausal osteoporosis
Externí odkaz:
https://doaj.org/article/133612481081496fa034b2b7e95c2653
Autor:
M. Yu. Frolov, M. V. Avksentyeva
Publikováno v:
Onkourologiâ, Vol 11, Iss 4, Pp 65-71 (2015)
Objective – to conduct pharmacoeconomic study of leuprolide acetate 45 mg once in 6 months (Eligard) for advanced prostate cancer from the perspective of Russian health care system Materials and methods. Cost minimization analysis (CMA) and budget
Autor:
N. M. Kolyasnikova, A. E. Platonov, N. A. Avksentyev, M. V. Avksentyeva, E.V. Derkach, A. V. Titkov, O. V. Platonova
Publikováno v:
Фармакоэкономика, Vol 8, Iss 1, Pp 47-56 (2015)
Study objective: to perform assessment of the social and economic burden (analysis of the cost of disease) of five natural focal transmitted infectious diseases in theRussian Federationon the whole and in certain regions: ixodic tick-borne borreliosi
Publikováno v:
Фармакоэкономика, Vol 8, Iss 4, Pp 50-61 (2016)
Aim. Hospital-based economic analysis for the use of thrombopoietin receptor agonists (TRA) Eltrombopag and Romiplostim has been performed in patients with chronic idiopathic thrombocytopenic purpura (ITP) at the background failure of previous treatm
Autor:
V. I. Ignat'eva, D. U. Ovsannikov, M. V. Avksentyeva, O. U. Rebrova, K. V. Gerasimova, I. G. Soldatova, G. A. Asmolova, L. L. Pankratyeva, E. A. Degtareva
Publikováno v:
Pediatričeskaâ Farmakologiâ, Vol 10, Iss 6, Pp 17-26 (2013)
Introduction. Respiratory syncytial virus (RSV) is one of the main causes of lower respiratory tract infections (LRTI) in infancy. In certain categories of children the risk of development of potentially lethal severe forms of the disease requiring h